Connect with us

International

Europe’s first cannabis tech accelerator to promote cannabis research

TechforCann Europe Accelerator is embarking on a collaboration to promote research and strengthen the cannabis tech ecosystem.

Published

on

Europe’s first cannabis tech accelerator to promote cannabis research

TechforCann Europe is entering into a strategic collaboration with Yissum, The Hebrew University of Jerusalem’s technology transfer company, and the University’s Multidisciplinary Center for Cannabinoid Research (MCCR).

Europe’s first tech accelerator dedicated to medical cannabis, TechforCann Europe, and the Hebrew University’s MCCR, have today announced the collaboration that aims to strengthen the European medical cannabis tech ecosystem and promote medical cannabis research.

MCCR at The Hebrew University of Jerusalem, home to the “godfather of cannabis research” professor Raphael Mechoulam, is the biggest cannabis research centre in Israel and one of the few in the world.

It conducts breakthrough research on cannabinoids, endocannabinoids and medical cannabis, with a focus on cancer, pain, inflammation and stress management, immunity, metabolism, drug delivery and nanotechnology, pharmaceutical chemistry, neuroscience and plant science and genetics.

Yissum was founded in 1964 and serves as a bridge between academic research and a global community of entrepreneurs, investors and industry.

CEO of TechforCann Europe, Lilac Mandeles, commented: “Partnering with such important and world-breaking institutions such as Yissum and the MCCR validates our goal of supporting early-stage IP-based startups from around the world who are solving challenges across the medical cannabis supply chain.

“We are excited to nurture and promote top-tier research that is currently being conducted, as well as offer our startups access to world-leading clinicians and researchers and cut the time to market for these remarkable innovations.”

To date, Yissum has registered more than 10,875 patents globally, licensed more than 1140 technologies and has spun out more than 191 companies. The company’s business partners span the globe and feature major names such as Boston Scientific, Google, ICL, Intel, Johnson & Johnson, Merck, Microsoft and Novartis.

TechforCann Europe identifies and nurtures early-stage IP based companies with potential for exit/IPO. The hybrid acceleration programme focuses on entrepreneurs who are solving challenges across the supply chain, with a focus on healthcare and biotech, digital health, precision agriculture and new product technologies. 

The programme enables participants to reach milestones faster, with less error and expense – increasing valuation and probability of commercial success.  

Under the agreement, TechforCann Europe will have access to a pipeline of innovative research projects that will benefit from the acceleration programme and the parties will collaborate for licensing or co-development of new products.

Under the agreement, MCCR affiliated researchers will act as advisory board members, mentors, and potential recruitment candidates for the startups that are accepted from around the world into the TechforCann Europe accelerator programme. 

Professor Yossi Tam, director of the MCCR, associate professor of pharmacology, and head of the Obesity and Metabolism Laboratory at Hebrew University, commented: “One of our major objectives at MCCR is to foster collaborations between our own teams and other groups around the globe who are conducting medical cannabis research. 

“One of our priorities is a cannabis-based synthetic API which may change people’s lives. 

“For example, we have recently completed pre-clinical work with a synthetic derivative of cannabinoid-acid, demonstrating its efficacy in treating obesity, and we have a lot more research in the pipeline.”

The agreement will also see the University’s medical cannabis online curriculum will also be available to international audiences through the accelerator platform.

International

Colombian-grown cannabis flower reaches Switzerland

The shipment follows updates to Colombia’s cannabis export policy.

Published

on

Colombian-grown cannabis flower reaches Switzerland
Home » News » International » Europe’s first cannabis tech accelerator to promote cannabis research

Allied Corp has shipped 1728kgs of Colombian-grown commercial cannabis flower to Switzerland. 

The shipment has been made as a part of the previously announced export approval of 7100kgs of Colombia-grown cannabis. This shipment of 1728kgs to Switzerland will be followed by 1500kgs weekly until the 7100kg threshold is met.

After the enactment of Colombia’s new legislation allowing for the legal export of dried cannabis produced in Colombia in April 2022, Allied submitted several applications for export. 

Read more: Colombia votes in pro-cannabis president Gustavo Petro

After receiving approval for export, Allied’s first export was shipped in June 2022 and the second shipment was in July 2022. This latest recurring shipment in August 2022 is now turning into a weekly cycle of 1500kgs.

This makes Allied Corp the first company to ship commercial cannabis flower from Colombia to an international market.

CEO and Chairman of the Allied Corp board, Calum Hughes, commented: “We are the first company ever to ship a Colombian commercial shipment of dried cannabis to an international market – now we are not only duplicating our shipments but are doing so at a commercial scale.

“This is the largest known legal shipment that we know of out of Colombia. This accomplishment speaks to the quality of our team, and most importantly our product.”

Allied has said that it has multiple strains in the production pipeline including over 15,000 THC plants created for multiple batches to fulfil its 2022 quota.

Hughes added: “From decades of production expertise, manufacturing and supply chain quality assurance, regulatory expertise and logistics coordination – the team has performed.

“The three years of genotyping and phenotyping followed by the regulatory knowledge needed to execute the export have proven successful.

“We can now boldly claim that we are not only the first to pull it off, but we have been able to duplicate the orders at commercial scale; the largest that we know of.

“We have now done it for three months in a row and are tightening this cycle to now ship 1500kgs every week.”

Continue Reading

International

Whitehouse remarks on “wrongful detainment” of Griner for Russian cannabis charges

The basketball star has been sentenced to nine years for allegedly smuggling cannabis medicines into Russia.

Published

on

Whitehouse remarks on “wrongful detainment” of Griner for Russian cannabis charges
Home » News » International » Europe’s first cannabis tech accelerator to promote cannabis research

American basketball player, Brittney Griner, aged 31, has been sentenced to nine years in prison in Russia after she was caught in possession of cannabis.

As well as a nine-year sentence for possession of vape cartridges containing cannabis, the WNBA star and two-time US Olympic champion has also been ordered to pay a fine of ₽1m (~£13,745).

Some reports have suggested that the development could see the US and Russia negotiating over a prisoner exchange.

Read more: Billy Hood CBD appeal reduces sentence to ten years

President Joe Biden’s office released a statement on the sentencing of what it describes as the “wrongfully detained” Griner, who has been detained since February,

Biden stated: “Today, American citizen Brittney Griner received a prison sentence that is one more reminder of what the world already knew: Russia is wrongfully detaining Brittney. 

“It’s unacceptable, and I call on Russia to release her immediately so she can be with her wife, loved ones, friends, and teammates.

“My administration will continue to work tirelessly and pursue every possible avenue to bring Brittney and Paul Whelan home safely as soon as possible.”

Griner’s agent, Lindsay Kagawa Colas, said the star was being used as a “political pawn”.

In a press briefing by White House press secretary Karine Jean-Pierre and NSC co-ordinator for strategic communications John Kirby, Jean-Pierre stated: “We have repeatedly called for Russia to release her immediately so she can be with her wife, loved ones, friends, and teammates.

“Under President Biden’s direction, the US government continues to work aggressively, pursuing every avenue to bring home Brittney, Paul Whelan, and every American held hostage and wrongfully detained around the world.

“As you all know, we have made a substantial offer to bring her and Paul Whelan home.  We urge Russia to accept that proposal.

“I’m not able to share more publicly at this time, but we are willing to take every step necessary to bring home our people, as we demonstrated with Trevor Reed. And that’s what we’re going to do here. I can assure you this is something the President and our national security team are focused on every single day.”

Griner has 10 days to appeal the verdict.

Continue Reading

International

Flora Growth partners with Colombia’s largest indigenous tribe in joint cannabis venture

“We are honoured to be given the opportunity to work hand-in-hand with the Misak people,” said Luis Merchan, Flora’s Chairman and CEO.

Published

on

Flora Growth Colombia

Flora Growth has entered an agreement with one of Colombia’s main indigenous tribes to process and distribute cannabis products.

Flora Growth has entered into a joint venture agreement with Pharma Indigena Misak Manasr Sas, the largest indigenous tribe in Colombia, on the development of cultivation best practices, manufacturing, export and marketing of cannabis and cannabis-containing products.

Under the agreement, the outdoor cultivator, manufacturer and distributor will provide Manasr regulatory advice, technical and business support related to product development and distribution, promotion of products to be marketed under the Flora brand portfolio, and cannabis derivatives to complete product production.

Additionally, Manasr will work closely with Flora in developing cannabis pharmaceuticals and products and help advance the approvals and authorisations required for exports of cannabis from Colombia.

“We are honoured to be given the opportunity to work hand-in-hand with the Misak people,” said Luis Merchan, Flora’s Chairman and CEO.

“Through this partnership, we will collaborate with the tribe on the processing and distribution of their Colombian-grown cannabis while offering Manasr a powerful platform for product distribution. In return, Flora will be able to leverage the tribe’s unique regulatory positioning to expedite exports and increase global market penetration of Colombian cannabis goods.

“We look forward to a long-standing relationship with such a powerful community partner.”

The initial term of the agreement is three years, however, the intention is to create a “lasting and mutually beneficial relationship for the foreseeable future”, the company said.

This announcement comes two weeks after Flora Growth’s CEO Luis Merchan met with Colombian Senator Gustavo Bolivar, the author of a new bill to legalise recreational cannabis.

Bolivar, the key author of the bill, and Merchan discussed the top tenants of the bill, the bill’s implications for companies such as Flora in Colombia and what legalisation means for the country’s burgeoning domestic and international cannabis markets.

Continue Reading
Sign up for the Cannabis Wealth newsletter

Recent Posts

[class^="wpforms-"]
[class^="wpforms-"]